-
EP4330236
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4330236
| EP4330236 - COMPOUNDS, COMPOSITIONS, AND METHODS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 02.02.2024 Database last updated on 28.05.2024 | |
| Former | The international publication has been made Status updated on 05.11.2022 | Most recent event Tooltip | 02.02.2024 | Publication in section I.1 EP Bulletin | published on 06.03.2024 [2024/10] | 02.02.2024 | Request for examination filed | published on 06.03.2024 [2024/10] | Applicant(s) | For all designated states Denali Therapeutics Inc. 161 Oyster Point Boulevard South San Francisco, California 94080 / US | [2024/10] | Inventor(s) | 01 /
BAGDASARIAN, Alex L. San Francisco, California 94080 / US | 02 /
BUCHER, Cyril San Francisco, California 94080 / US | 03 /
CRAIG, II, Robert A. San Francisco, California 94080 / US | 04 /
DE VICENTE FIDALGO, Javier San Francisco, California 94080 / US | 05 /
ESTRADA, Anthony A. San Francisco, California 94080 / US | 06 /
FOX, Brian M. San Francisco, California 94080 / US | 07 /
HU, Cheng San Francisco, California 94080 / US | 08 /
HUFFMAN, Benjamin J. San Francisco, California 94080 / US | 09 /
LEXA, Katrina W. San Francisco, California 94080 / US | 10 /
NILEWSKI, Lizanne G. San Francisco, California 94080 / US | 11 /
OSIPOV, Maksim San Francisco, California 94080 / US | 12 /
THOTTUMKARA, Arun San Francisco, California 94080 / US | [2024/10] | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [2024/10] | Application number, filing date | 22796883.1 | 29.04.2022 | [2024/10] | WO2022US27118 | Priority number, date | US202163182741P | 30.04.2021 Original published format: US 202163182741 P | US202163256393P | 15.10.2021 Original published format: US 202163256393 P | WO2021US60088 | 19.11.2021 Original published format: PCT/US2021/060088 | [2024/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022232632 | Date: | 03.11.2022 | Language: | EN | [2022/44] | Type: | A1 Application with search report | No.: | EP4330236 | Date: | 06.03.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.11.2022 takes the place of the publication of the European patent application. | [2024/10] | Search report(s) | International search report - published on: | US | 03.11.2022 | Classification | IPC: | C07D239/42, C07D401/04, C07D401/12 | [2024/10] | CPC: |
C07D401/12 (EP);
A61P1/16 (EP);
A61P25/28 (EP);
A61P29/00 (EP);
C07D217/24 (EP);
C07D221/20 (EP);
C07D401/14 (EP);
C07D405/12 (EP);
C07D405/14 (EP);
C07D409/12 (EP);
C07D413/12 (EP);
C07D417/12 (EP);
C07D417/14 (EP);
C07D453/02 (EP);
C07D471/04 (EP);
C07D487/04 (EP);
C07D491/048 (EP);
C07D491/052 (EP);
C07D491/107 (EP);
C07D495/04 (EP);
C07D498/04 (EP);
C07D513/04 (EP)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/10] | Extension states | BA | 13.11.2023 | ME | 13.11.2023 | Validation states | KH | 13.11.2023 | MA | 13.11.2023 | MD | 13.11.2023 | TN | 13.11.2023 | Title | German: | VERBINDUNGEN, ZUSAMMENSETZUNGEN UND VERFAHREN | [2024/10] | English: | COMPOUNDS, COMPOSITIONS, AND METHODS | [2024/10] | French: | COMPOSÉS, COMPOSITIONS ET PROCÉDÉS | [2024/10] | Entry into regional phase | 13.11.2023 | National basic fee paid | 13.11.2023 | Search fee paid | 13.11.2023 | Designation fee(s) paid | 13.11.2023 | Examination fee paid | Examination procedure | 13.11.2023 | Examination requested [2024/10] |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2012121992 (LEXICON PHARMACEUTICALS INC [US], et al) [A] 1-12 * , especially: pg 50, In 15-18, scheme, product. *; | [A]US2019106436 (CHAKRAVARTY SARVAJIT [US], et al) [A] 1-12 * , especially: pg 166, Compound 1.497. *; | [A]WO2021080359 (SK BIOPHARMACEUTICALS CO LTD [KR]) [A] 1-12 * , especially: pg 39, bottom, formula. *; | [PX]WO2022109268 (DENALI THERAPEUTICS INC [US]) [PX] 1-12* , entire document. * |